Literature DB >> 8904759

A novel presenilin 1 mutation resulting in familial Alzheimer's disease with an onset age of 29 years.

D Campion1, A Brice, C Dumanchin, M Puel, M Baulac, V De La Sayette, D Hannequin, C Duyckaerts, A Michon, C Martin, V Moreau, C Penet, M Martinez, F Clerget-Darpoux, Y Agid, T Frebourg.   

Abstract

We have identified a novel Alzheimer's disease family in which affected subjects had a very young age of onset (range 29-35 years). Neuropathological confirmation of the diagnosis was obtained for one patient. Molecular analysis shows that within this family the disease results from a missense mutation at codon 235 of the presenilin 1 (PS-1) gene. Two patients had exhibited generalized tonico-clonic seizures several years before the onset of dementia. Whether this particular clinical feature is a consequence of the PS-1 mutation remains to be established. The Leu235Pro mutation is, to our knowledge, the PS-1 mutation associated with the youngest age of AD onset, which suggests that it has a drastic effect on PS-1 function.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8904759     DOI: 10.1097/00001756-199607080-00009

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  14 in total

Review 1.  Presenilins: structural aspects and posttranslational events.

Authors:  F Checler
Journal:  Mol Neurobiol       Date:  1999-06       Impact factor: 5.590

Review 2.  Genetic risk factors in Alzheimer's disease.

Authors:  L Tilley; K Morgan; N Kalsheker
Journal:  Mol Pathol       Date:  1998-12

3.  Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model.

Authors:  Caty Casas; Nicolas Sergeant; Jean-Michel Itier; Véronique Blanchard; Oliver Wirths; Nicolien van der Kolk; Valérie Vingtdeux; Evita van de Steeg; Gwenaëlle Ret; Thierry Canton; Hervé Drobecq; Allan Clark; Bruno Bonici; André Delacourte; Jesús Benavides; Christoph Schmitz; Günter Tremp; Thomas A Bayer; Patrick Benoit; Laurent Pradier
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307

4.  Neuronal Network Excitability in Alzheimer's Disease: The Puzzle of Similar versus Divergent Roles of Amyloid β and Tau.

Authors:  Syed Faraz Kazim; Joon Ho Seo; Riccardo Bianchi; Chloe S Larson; Abhijeet Sharma; Robert K S Wong; Kirill Y Gorbachev; Ana C Pereira
Journal:  eNeuro       Date:  2021-04-23

Review 5.  Correlating familial Alzheimer's disease gene mutations with clinical phenotype.

Authors:  Natalie S Ryan; Martin N Rossor
Journal:  Biomark Med       Date:  2010-02       Impact factor: 2.851

6.  Novel mutations and repeated findings of mutations in familial Alzheimer disease.

Authors:  Ulrich Finckh; Christian Kuschel; Maria Anagnostouli; Efstratios Patsouris; George V Pantes; Stylianos Gatzonis; Elisabeth Kapaki; Panagiota Davaki; Katrin Lamszus; Dimitrios Stavrou; Andreas Gal
Journal:  Neurogenetics       Date:  2005-03-18       Impact factor: 2.660

7.  De novo presenilin 1 mutations are rare in clinically sporadic, early onset Alzheimer's disease cases. French Alzheimer's Disease Study Group.

Authors:  C Dumanchin; A Brice; D Campion; D Hannequin; C Martin; V Moreau; Y Agid; M Martinez; F Clerget-Darpoux; T Frebourg
Journal:  J Med Genet       Date:  1998-08       Impact factor: 6.318

Review 8.  Neurologic and motor dysfunctions in APP transgenic mice.

Authors:  Robert Lalonde; Ken-Ichiro Fukuchi; Catherine Strazielle
Journal:  Rev Neurosci       Date:  2012       Impact factor: 4.353

Review 9.  Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene.

Authors:  A J Larner; M Doran
Journal:  J Neurol       Date:  2005-11-04       Impact factor: 6.682

10.  Seizures as an early symptom of autosomal dominant Alzheimer's disease.

Authors:  Jonathan Vöglein; Soheyl Noachtar; Eric McDade; Kimberly A Quaid; Stephen Salloway; Bernardino Ghetti; James Noble; Sarah Berman; Jasmeer Chhatwal; Hiroshi Mori; Nick Fox; Ricardo Allegri; Colin L Masters; Virginia Buckles; John M Ringman; Martin Rossor; Peter R Schofield; Reisa Sperling; Mathias Jucker; Christoph Laske; Katrina Paumier; John C Morris; Randall J Bateman; Johannes Levin; Adrian Danek
Journal:  Neurobiol Aging       Date:  2018-12-05       Impact factor: 5.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.